Chronic kidney disease with high proteinuria
Clinical trials for Chronic kidney disease with high proteinuria explained in plain language.
Never miss a new study
Get alerted when new Chronic kidney disease with high proteinuria trials appear
Sign up with your email to follow new studies for Chronic kidney disease with high proteinuria, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to protect kidneys in High-Risk patients
Disease control OngoingThis Phase 2 study tests whether a combination of two drugs, zibotentan and dapagliflozin, works better than dapagliflozin alone at reducing protein leakage in urine for adults with chronic kidney disease. About 224 participants will receive either the combo or the single drug. T…
Matched conditions: CHRONIC KIDNEY DISEASE WITH HIGH PROTEINURIA
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill combo aims to slow kidney decline in High-Risk patients
Disease control OngoingThis Phase 3 trial tests whether adding zibotentan to the standard drug dapagliflozin can better protect kidney function in people with chronic kidney disease and high proteinuria. About 1,800 adults are taking either the combo or dapagliflozin alone. The main goal is to see if t…
Matched conditions: CHRONIC KIDNEY DISEASE WITH HIGH PROTEINURIA
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC